Related Experiment Video
Updated: May 17, 2026
07:48
Tracking Drug-induced Changes in Receptor Post-internalization Trafficking by Colocalizational Analysis
Published on: July 3, 2015
Why do cannabinoid receptors have more than one endogenous ligand?
Vincenzo Di Marzo1, Luciano De Petrocellis
1Endocannabinoid Research Group, Istituto Chimica Biomolecolare, CNR, Via Campi Flegrei 34, Comprensorio Olivetti, 80078 Pozzuoli, NA, Italy. vdimarzo@icb.cnr.it
Summary
The endocannabinoid system involves cannabinoid receptors and ligands like anandamide. New research explores how anandamide and 2-arachidonoylglycerol (2-AG) interact with TRPV1 channels, impacting homeostasis.
Area of Science:
- Neuroscience
- Pharmacology
- Cell Biology
Background:
- The endocannabinoid system comprises G-protein-coupled receptors (GPCRs), endogenous ligands (endocannabinoids), and regulatory proteins.
- Cannabinoid receptors (CB1, CB2) have multiple endogenous agonists, a unique characteristic among GPCRs.
Purpose of the Study:
- To explore the interaction between endocannabinoids and transient receptor potential of vanilloid type-1 (TRPV1) channels.
- To elucidate the physiological significance of multiple endocannabinoid agonists and their diverse receptor targets.
Main Methods:
- Review of existing literature on endocannabinoid signaling.
- Analysis of studies investigating anandamide and 2-arachidonoylglycerol (2-AG) interactions with cannabinoid receptors and TRPV1 channels.
Main Results:
- Anandamide activates both cannabinoid receptors and TRPV1 channels.
- N-arachidonoyldopamine, another endocannabinoid, activates TRPV1 but not CB1/CB2 receptors.
- 2-AG primarily acts on cannabinoid receptors, with limited TRPV1 activation.
Conclusions:
- The differential actions of anandamide and 2-AG at cannabinoid receptors and TRPV1 contribute to the endocannabinoid system's versatility.
- TRPV1 channels may function as ionotropic endocannabinoid receptors, expanding the signaling network.
- This complex signaling network allows organisms to finely tune physiological homeostasis.
Related Concept Videos
01:22Opioid Receptors: Overview
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2, D-Pen5]-enkephalin or DPDPE for...
01:29The Two-State Receptor Model
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with one...
The binding affinity of a drug determines its interaction with one...
01:30Spare Receptors
Some receptors remain unoccupied even when an agonist produces a maximal response. Such empty ones are called spare receptors. In presence of spare receptors the maximum effect of an agonist drug is achieved with fewer than 100% of the receptors being occupied. To determine the presence of spare receptors, scientists often compare the concentration of the drug needed to produce 50% of the maximum effect (EC50) with the concentration of the drug needed to occupy 50% of the receptors (Kd). If the...
01:29Drug-Receptor Interactions
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue.
01:25Drug-Receptor Interaction: Agonist
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous ligand's action.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous ligand's action.
01:12GPCR Desensitization
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...